Sort
15,842 grants matching “pancreatic cancer”
Function and Regulation Mechanisms of Polo-like Kinase 3 in Pancreatic Cancer
$298,934Paul J Chiao · University Of Tx Md Anderson Can Ctr · R01 · FY2013 · CA
Functional Validation of Pancreatic Cancer Progression Biomarker
$298,934Keping Xie · University Of Tx Md Anderson Can Ctr · R01 · FY2013 · CA
Coordination of SR Protein Phosphorylation and RNA Splicing
$298,923Joseph A Adams · University Of California, San Diego · R01 · FY2009 · GM
Retargeting FDA Approved Anticancer Liposomal Drugs to Cancer Stem Cells
$298,920Francis C Szoka · Zoneone Pharma, Inc. · R41 · FY2015 · CA
Regulation of the ATM/ATR-p53 DNA Damage Signaling Pathway by the Wip1 Phosphatas
$298,800Xiongbin Lu · University Of South Carolina At Columbia · R01 · FY2009 · CA
Regulation of the ATM/ATR-p53 DNA Damage Signaling Pathway by the Wip1 Phosphatas
$298,800Xiongbin Lu · University Of South Carolina At Columbia · R01 · FY2010 · CA
Development of a DCLK1 siRNA Nanoparticle as Targeted Therapy to Treat Pancreatic Cancer
$298,791Sripathi M Sureban · Coare Holdings, Inc. · R44 · FY2018 · CA
Protein Kinase D in oncogenic oxidative stress signaling
$298,713Peter Storz · Mayo Clinic Jacksonville · R01 · FY2014 · CA
Mutant mouse models of exocrine pancreatic cancer
$298,713David Tuveson · University Of Pennsylvania · R01 · FY2006 · CA
Development of Targeted Nanotechnology Platform for Pancreatic Cancer
$298,584Subhash C. Chauhan · University Of Texas Rio Grande Valley · R01 · FY2019 · CA
Targeted Drug Delivery to Surface Receptors.
$298,567Francis C Szoka · University Of California, San Francisco · R01 · FY2015 · GM
Targeted Drug Delivery to Surface Receptors.
$298,567Francis C Szoka · University Of California, San Francisco · R01 · FY2014 · GM
Targeted Drug Delivery to Surface Receptors.
$298,567Francis C Szoka · University Of California, San Francisco · R01 · FY2012 · GM
Development Control in C. elegans
$298,538Min Han · University Of Colorado · R01 · FY2017 · GM
MSM-Multi-scale Analysis of Cellular Force Transmission and Biochemical Activatio
$298,478Massachusetts Institute Of Technology · R01 · FY2005 · GM
Zinc enrichment/zinc sensing mechanism through the extracellular domain of ZIP4
$298,460Jian Hu · Michigan State University · R01 · FY2015 · GM
Great Lakes/New England Clinical Epidemiology/Validation
$298,416Dean E. Brenner · University Of Michigan At Ann Arbor · U01 · FY2010 · CA
The anti-senescence activity of trefoil factor 1
$298,354Xiao-Fan Wang · Duke University · R01 · FY2013 · CA
Mechanistic Studies on New Platinum Clinical Agents
$298,321Nicholas P Farrell · Virginia Commonwealth University · R01 · FY2006 · CA
A novel glutaminase-free mammalian asparaginase with minimized immunogenicity to enable expanded use in cancer therapy
$298,305Hien-Anh Nguyen · Enzyme By Design, Inc. · R41 · FY2018 · CA
FrostBite-DMR - A New Drug-Free Approach for Treating Type 2 Diabetes
$298,280J M Baust · Cell Preservation Services, Inc. · R43 · FY2022 · DK
NK Cell Biology
$298,169Lewis L. Lanier · University Of California, San Francisco · R01 · FY2009 · CA
Reaction pathways of lipid oxyl radicals and DNA damage
$298,156Vladimir Shafirovich · New York University · R01 · FY2006 · ES
Analysis of Patient Tumor Responses to Apo2L/TRAIL
$298,135Elizabeth Repasky · Roswell Park Cancer Institute Corp · R01 · FY2007 · CA
NK Cell Biology
$298,050Lewis L. Lanier · University Of California, San Francisco · R01 · FY2010 · CA